NewGenIvf Group Ltd · Misc Health & Allied Services, NEC

NIVF

Moderate riskNext report: Not enough history

View price ↗

The short version

A profitable company with growing sales.

Going well

Profitable, keeps 42% of sales as profit
Sales up 336% last year
No debt reported

Money moves

No insider buying or selling in the last 30 days

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$1.15-16.7% that day

From NIVF's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

3/6Mixed

PassReturn on equity 15%+Earns a lot on the money owners have in the business.77.2%
PassDebt under half of equityNot relying on borrowed money.No debt reported
PassNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.41.7%
MissProfitable every yearSteady profits, not one good year.3 of 5 years
MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$11.1M
MissGross margin 40%+Pricing power: sells for well above what it costs to make.4.0%

Revenue: $23.7M; +336.3% vs prior year
Total debt: None; 0.00x equity
Current ratio: 3.12x; short-term assets / bills due
Free cash flow: -$11.1M; -46.7% of revenue

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: share count not growing. A checklist is a starting point for research, not a verdict.

Insider rating

Last 90 days

No open-market insider buys or sells in the last 90 days.

Weekly insider trend

No trades to chart yet.

Filing buzz

Last 7 days vs normal

31/ 100

This week: 1
Normal week: 2.0
vs normal: 0.5x

SEC filings of any kind. 50 means a normal week.

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

-64.5%

Cash runwayAt last year's cash burn

1 months

Debt to equityLatest balance sheet: debt compared with what owners have

No debt reported

Shares outstandingLatest reported

27K

Why moderate risk

Revenue down 13% from the year before
5 offering filings in 6 months (may sell new shares)

Earnings reports

Last 0

Next reportNot enough history

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

F-3Oct 27 · View filing ↗Offering 5%+ holder update (active)Oct 6 · View filing ↗Activist Offering prospectusSep 30 · View filing ↗Offering F-1/ASep 10 · View filing ↗Offering F-1/ASep 1 · View filing ↗Offering F-1Aug 20 · View filing ↗Offering

Insider trades

Open-market buys and sells, last 90 days

No open-market buys or sells in 90 days. Grants and option exercises are left out.

"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.

Latest filings

Straight from SEC EDGAR

6-K/AOct 27 · Form 6-K/A ↗F-3Oct 27 · Form F-3 ↗6-KOct 21 · Form 6-K ↗DRSOct 9 · Form DRS ↗6-KOct 7 · Form 6-K ↗6-KOct 7 · Form 6-K ↗

Option exerciseHei Yue Tina FongChief Marketing Officer, Director

139,811 shares at $0.00 · $14

+2211% of holdings
Now owns 146,133 shares
Exercise price $0.00
Filed 1 day after trade

Oct 5Form 4 ↗

Option exerciseWing Fung Alfred SiuChairman & CEO, Director

139,811 shares at $0.00 · $14

+2212% of holdings
Now owns 146,132 shares
Exercise price $0.00
Filed 1 day after trade

Oct 5Form 4 ↗

5%+ holder update (active)Oct 6 · Form SCHEDULE 13D/A ↗6-KOct 5 · Form 6-K ↗Offering prospectusSep 30 · Form 424B4 ↗6-KSep 30 · Form 6-K ↗EFFECTSep 28 · Form EFFECT ↗F-1/ASep 10 · Form F-1/A ↗New insiderSep 4 · Form 3 ↗

Source: SEC EDGAR filings. For informational purposes. Not investment advice.

Report a problem with this page